Our Supporters How to Participate in Precision Panc Remit of Scientific Advisory Board Meeting Minutes Membership Remit of Therapeutic Testing Board Meeting Minutes Precision Panc Therapeutic Testing Board Membership Remit of Steering Committee Patient Stories Steering Group Members Therapeutic Testing Board Meetings PRIMUS 002 PRIMUS 001 Working with the NHS Patient Public Engagement Meetings Steering Committee Scientific Advisory Board Governance Structure Governance Master Protocol Kick Off Meeting News Clinicians Area Clinical Trials What is precision medicine? Information and Support What is Pancreatic Cancer? Research History Current Research Our Researchers Privacy Policy Patients and Carers Contact Us About us Home
Precision-Panc Recruits Patient 200! Precision-Panc Brochure Royal Bournemouth Hospital Opens Finding the right treatment for the patient CRUK animate the Precision-Panc platform CRUK / Precision-Panc Video Professor Biankin receives the Order of Australia in Queen’s Birthday Honours Precision-Panc opens its 20th Site Precision Panc Spring Newsletter Precision-Panc Opens Site 19 Recent Media Pieces Regarding 100 Patient Milestone Site 17 opens for Precision-Panc PRIMUS 002 opens Informing the Future of Genomic Medicine in Scotland Report is Published St James’s University Hospital Opens Precision-Panc Opens its 15th site Glasgow Experts Lead UK Pancreatic Cancer Research 11th site opens to PRECISION-Panc Scotsman Conferences Blogspot November is Pancreatic Cancer Awareness Month First Precision-Panc Trial Opens In Glasgow Cancer Research UK Investment Landscape of pancreatic neuroendocrine cancer Whole Genome Sequencing from EUS biopsies Upcoming Pancreas 2016 Conference Scottish Genome Partnership Announced Identification of four Pancreatic Cancer subtypes offers new treatment insight into the disease First Minister announces £4m ‘Precision Medicine Ecosystem’
Home | About us

“Working to find the right trial for people with pancreatic cancer”

About Us

In 2017 the Precision-Panc Platform was founded, bringing together expertise in pancreatic cancer from the University of Glasgow, CRUK Beatson Institute, CRUK Cambridge Institute, CRUK Manchester Institute, the Institute of Cancer Research in London, the University of Oxford and the NHS.

With 10,000 patients diagnosed annually in the UK with pancreatic cancer (330,000 worldwide) and 9,300 deaths a year, by 2025 pancreatic cancer is predicted to be the second most lethal cancer after lung cancer. Pancreatic cancer is a very complex cancer with little in the way of effective treatments.

There is now a UK wide network of over 20 hospitals that can offer precision medicine clinical trials to patients with pancreatic cancer.

Precision medicine clinical trials, based in the genomics of the patient and their tumour, offers hope for the 85% of pancreatic cancer patients who are not eligible for surgery

In Precision-Panc all registered patients have their genome testing using Glasgow Precision Oncology Laboratories bespoke panel. For more information regarding GPOL please click the button below

There is excellent evidence that participation in clinical trials is associated with better outcomes for patients. Networked clinical trials with researchers across the country share expertise and knowledge, as well as creating and sharing infrastructure, leading to trials which are quicker to set up and recruit.

At Precision-Panc the focus is on the patient, and we work closely with a Patient Advisory Group organised through Pancreatic Cancer UK and Cancer Research UK.

Precision-Panc also enjoys broad stakeholder support from pancreatic cancer charities, patient organisations and industry partners

© 2019 Precision Panc
Web design by Creatomatic
This site uses cookies.
Read our privacy policy

This site uses cookies for marketing, personalisation, and analysis purposes. You can opt out of this at any time or view our full privacy policy for more information.